John Blankenhorn

John Blankenhorn

InvestorPlace Contributor

Expertise: Biochemistry, biotechnology and pharmaceutical research

John Blankenhorn has been a researcher since 2016 and has years of experience and publications on the topics of biochemistry, biotechnology, and pharmaceutical research. His main interests are the application of biology and biotechnology to our daily lives, as well as the use of Machine Learning and AI to speed up research and development in the life sciences. He currently works at Emory University studying the structural basis of Alzheimer’s Disease.

Recent Articles

3 Large-Cap Biotech Stocks to Hold for the Long Haul

By John Blankenhorn, InvestorPlace Contributor

Three large-cap biotech stocks to buy and hold for the long haul

The Next Big Disruptors? 3 Biotech Stocks Making Headlines.

By John Blankenhorn, InvestorPlace Contributor

Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023.

Load More